New York State Common Retirement Fund’s CASI Pharmaceuticals CASI Stock Holding History

New York State Common Retirement Fund’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-51	Closed	-$1K	–	3360
2021 Q2	$1K	Sell	51 -3,919	-99%	-$65.9K	﹤0.01%	3374
2021 Q1	$95K	Hold	3,970	–	–	﹤0.01%	3084
2020 Q4	$117K	Hold	3,970	–	–	﹤0.01%	2962
2020 Q3	$61K	Hold	3,970	–	–	﹤0.01%	3097
2020 Q2	$99K	Hold	3,970	–	–	﹤0.01%	2954
2020 Q1	$81K	Hold	3,970	–	–	﹤0.01%	2835
2019 Q4	$123K	Hold	3,970	–	–	﹤0.01%	2940
2019 Q3	$133K	Hold	3,970	–	–	﹤0.01%	2945
2019 Q2	$127K	Hold	3,970	–	–	﹤0.01%	3023
2019 Q1	$114K	Hold	3,970	–	–	﹤0.01%	2922
2018 Q4	$160K	Hold	3,970	–	–	﹤0.01%	2802
2018 Q3	$185K	Hold	3,970	–	–	﹤0.01%	2861
2018 Q2	$327K	Buy	+3,970	New	+$268K	﹤0.01%	2638

Other funds holding CASI

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

IACGFIA

IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

WSC

Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

New York State Common Retirement Fund's CASI Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of CASI Pharmaceuticals (CASI) in Q3 2021, closing a stake of 51 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in CASI in Q2 2018 and held it in 13 quarters. The position peaked at $327K in Q2 2018. 58 funds tracked by Wall St. Rank hold CASI as of Q3 2021.

New York State Common Retirement Fund reported no remaining CASI Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 51 CASI Pharmaceuticals shares in Q3 2021, an estimated $1K.
New York State Common Retirement Fund first reported a position in CASI Pharmaceuticals in Q2 2018 and held it in 13 quarters.
New York State Common Retirement Fund's CASI Pharmaceuticals position peaked at $327K in Q2 2018.
58 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.